Physician profile
Mitchell A Bernstein
NPI 1447251095
$36,218.54
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,010 · 2021: $2,418 · 2022: $17K · 2023: $15K · 2024: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,677.50 |
| Food and Beverage | $719.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $34,706.77 | 2021-2023 | Truelok, Tl-Hex Truelok Hexapod System |
| Intuitive Surgical, INC. | $642.86 | 2019 | |
| Smith+Nephew, INC. | $210.00 | 2019 | |
| Becton, Dickinson and Company | $207.94 | 2024 | Phasix Mesh |
| Virtual Incision Corporation | $154.00 | 2024 | Mira |
| Palette Life Sciences, INC. | $142.50 | 2019 | |
| Guard Medical INC. | $110.96 | 2023 | Npseal Medium, Npseal Large, Npseal (5) |
| Takeda Pharmaceuticals U.S.A., INC. | $28.64 | 2021 | |
| Boston Scientific Corporation | $14.87 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.